Free Submission Public Relations &
Deutsch English


INC Research CEO & COO Participate in Partnerships in Clinical Trials 2013

Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-04-22 16:32:02 -

Global CRO's executive leaders offer insights in managing outsourcing risk and
                    optimizing data in clinical development

Raleigh, N.C., Apr. 22, 2013 - INC Research, LLC, a therapeutically focused
global clinical research organization (CRO) with a Trusted Process® for
delivering reliable results, today announced CEO Jamie Macdonald and COO
Alistair Macdonald will participate in key panel discussions at this year's
Partnerships in Clinical Trials conference, April 21-24, 2013, in Orlando,
Florida. Together with Vice President, Strategic Alliances Andrew Townshend,
they will participate in four educational sessions covering a range of topics,
including managing risk in outsourced clinical trials, translating data into
meaningful insights and capturing metrics in a partnership.

"The Partnerships conference 
is a perfect forum for coming together and exchanging ideas with other industry leaders," said INC Research CEO Jamie Macdonald. "As a leader in clinical innovation, we look forward to sharing some of the forward-thinking strategies and tools we've been employing to drive overall improvements in efficiency and quality in the drug development process. Through innovation, our metrics-driven Trusted Process(®) and our extensive therapeutic expertise, we're helping biopharms make better use of their drug development capital." INC Research Speaker Lineup at Partnerships: * Executive Leadership Boardroom - CEO Jamie Macdonald will participate in a Quick-Fire Q&A session along with other invited CRO leaders as part of this inaugural event on Monday, April 22,at 3:15 p.m. Attendees of this invitation-only event will have an opportunity to connect and exchange ideas on designing the clinical trial landscape of the future with C-level executives from the top CROs. * Jamie Macdonald also will participate in the "Managing Risk in Outsourced Clinical Trials through Risk Assessment, Risk Sharing and Risk-based Management Approaches," panel discussion taking place Tuesday, April 23, from 1:30-2:15 p.m. * COO Alistair Macdonald will participate in a panel on "Translating Data into Meaningful Insights: Optimizing the Interface Among Key Stakeholders," also taking place Tuesday, April 23, from 1:30-2:15 p.m. * Andrew Townshend, Vice President of Strategic Alliances, will present "Capturing Metrics in a Partnership: Does Fortune Favor the Brave?" on Wednesday, April 24, from 11:30 a.m.-12:10 p.m. As a leading CRO providing a full range of Phase I to IV clinical development services on a worldwide scale, INC Research helps biopharms efficiently bring new drugs to market through a proven methodology that ensures consistent quality, reduced trial variability and complete transparency for every phase of a development program. Using advanced data monitoring and management systems, INC Research is able to provide a real-time status on all projects and test sites and help identify issues before they occur, giving sponsors a high level of visibility and predictability throughout their clinical trial programs. For more information or to schedule a meeting at Partnerships in Clinical Trials, visit the INC Research site or stop by Booth #219 at the conference. About INC Research INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process(®) methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit or follow us at @inc_research. Contact: Lori Dorer, Media +1 (513) 345-1685 This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: INC RESEARCH, LLC via Thomson Reuters ONE [HUG#1694944]

Press Information:

Contact Person:

Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact